Internet-Based Drug Prevention Education for College Students

描述(由申请者提供)：本申请建议开发和测试一个针对大学生的互动式在线药物使用预防计划，MyStudentBody-Druits(MSB-Druits)。针对一级和二级预防，MSB药物将促进预防开始或减少药物使用和相关危险行为的动机。与酒精相比，校园里预防吸毒被忽视了，尽管吸毒很普遍，后果很严重。大麻是使用最广泛的非法药物，其次是非医疗用途的处方药，包括兴奋剂(右旋苯丙胺、苯乙酸甲酯)和阿片类药物(羟考酮、氢可酮)。2003年，大约10%的高中生报告了氢可酮的非医疗用途，使其成为这一群体中第三大滥用物质，仅次于大麻和苯丙胺。从2002年到2003年，在大学年龄的年轻人中滥用羟考酮增加了近40%。将处方药与酒精等其他药物混合，进一步增加药物相互作用和过量服药的风险。为大学生提供方便和有效的毒品预防的公共卫生需求是显而易见的。最近的NIDA倡议认识到这一需要(《处方药滥用》，PA-01-110；Volkow，2005年)。MSB-Druits将利用技术和丰富的媒体纳入关键的循证预防特征，包括个人风险评估和量身定做的反馈以促进动机，有关不同药物和成瘾的相关教育以促进准确的风险评估，以及技能建设活动以促进拒绝和应对技能和自我效能。第一阶段涉及概念论证研究，以证明产品的可行性。第二阶段将包括一个完全运行的MSB药物网站的生产和可用性测试，以及一个随机对照试验，以评估影响与药物相关的知识、态度和行为的计划有效性。

DESCRIPTION (provided by applicant): This application proposes development and testing of an interactive, online drug use prevention program for college students, MyStudentBody-Drugs (MSB-Drugs). Geared toward primary and secondary prevention, MSB-Drugs will promote motivation to prevention initiation of, or reduce, drug use and associated risk behaviors. Compared to alcohol, drug use prevention is neglected on campuses, despite the prevalence of use and significant consequences. Marijuana is the most widely used illicit drug, followed by non-medical use of prescription drugs, including stimulants (dextroamphetamine, methyphenidate) and opioids (oxycodone, hydrocodone). In 2003, roughly 10 percent of high school seniors reported non- medical use of hydrocodone, making it the third most abused substance for this group, after marijuana and amphetamines. From 2002 to 2003, abuse of oxycodone increased by nearly 40 percent among college- aged youth. Mixing prescription drugs with other drugs, such as alcohol, further increases risk for drug interactions and overdose. The public health need for easily accessible and effective drug prevention for college students is clear. Recent NIDA initiatives recognize this need (Prescription Drug Abuse, PA-01-110; Volkow, 2005). MSB-Drugs will use technology and rich media to incorporate key evidence-based prevention features, including personal risk assessments with tailored feedback to promote motivation, relevant education about different drugs and addiction to foster accurate risk appraisals, and skill-building activities to promote refusal and coping skills and self-efficacy. Phase I involved proof of concept research to demonstrate product feasibility. Phase II will involve production and usability testing of a fully operational MSB-Drugs website, and a randomized, controlled trial to assess program efficacy for influencing drug- related knowledge, attitudes, and behaviors.